Sandwich, United Kingdom

Adam Gillmore

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adam Gillmore

Introduction

Adam Gillmore is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work focuses on novel compounds that have the potential to treat serious medical conditions.

Latest Patents

Gillmore's latest patents include innovative polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one. These polymorphic forms are crucial as they may serve as components of pharmaceutical compositions aimed at treating diseases mediated by poly(ADP-ribose) polymerase activity, including cancer. The processes for their preparation are also detailed in his patents, showcasing his commitment to advancing medical science.

Career Highlights

Adam Gillmore is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative drug formulations.

Collaborations

Gillmore collaborates with esteemed colleagues such as Patricia Ann Basford and Anthony Michael Campeta. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Adam Gillmore's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to impact the treatment of serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…